Intellectual Property Cases
Cases 11 - 20 of 52
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv01291
Defendant: Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff: Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
SALIX PHARMACEUTICALS, INC. et al v. ZYDUS PHARMACEUTICALS (USA), INC. et al
as 2:2022cv05589
Plaintiff: SALIX PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, LTD. and BAUSCH HEALTH COMPANIES INC.
Defendant: ZYDUS PHARMACEUTICALS (USA), INC., ZYDUS WORLDWIDE DMCC and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court: Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al
as 2:2022cv02964
Plaintiff: ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH
Defendant: ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2022cv01882
Plaintiff: NEUROCRINE BIOSCIENCES, INC.
Defendant: ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2022cv00439
Defendant: Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff: Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 1:2022cv01882
Plaintiff: NEUROCRINE BIOSCIENCES, INC.
Defendant: ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Zydus Worldwide DMCC et al
as 1:2022cv00297
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PFIZER INC. et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 1:2022cv00899
Plaintiff: PFIZER INC., WARNER-LAMBERT COMPANY LLC and PF PRISM IMB B.V.
Defendant: ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC and CADILA HEALTHCARE, LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PFIZER INC. et al v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2022cv00899
Plaintiff: PFIZER INC., WARNER-LAMBERT COMPANY LLC and PF PRISM IMB B.V.
Defendant: ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC and CADILA HEALTHCARE, LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?